Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GZMO -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (31)	2/10/1999 9:05:00 AM
From: jeffbas	Read Replies (1) \| Respond to of 438

Another thought. It is hard to believe that Children's Hospital did not know about the problems Entremed and Bristol Myers were having. It also seems unlikely that Genzyme would have known. The key question becomes whether Children's Hospital really licensed this "next generation" compound to GZMO becuse of Genzyme's capabilities as stated, or because they knew they could not get any more upfront money out of the other group in view of the poor progress/results, and had to look around for some other (fill in a word).